米氮平（瑞美吉仑）用于治疗难治性妊娠剧吐：挽救双胎妊娠
Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy.
作者信息
Rohde Anke, Dembinski Joerg, Dorn Christoph
机构信息
Department of Psychosomatics in Gynecology, Women's University Hospital Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany.
出版信息
Arch Gynecol Obstet. 2003 Aug;268(3):219-21. doi: 10.1007/s00404-003-0502-0. Epub 2003 Jun 18.
CASE REPORT
We present the case of a 25-year-old woman with treatment resistant hyperemesis gravidarum in the 15th week with a 13 kg loss of body weight. When the patient asked for termination of the pregnancy because of the unbearable symptoms, treatment with intravenous mirtazapine (Remergil) was started.
RESULTS
Nausea and vomiting disappeared within hours, pregnancy termination was no longer desired. The patient was discharged two weeks later in good health and at 36 weeks gestation a cesarean section was performed. Post partum evaluation as well as 6-month post-partum revealed no dysmorphology or laboratory abnormalities in the children.
病例报告
我们报告一例25岁女性，妊娠15周时患有难治性妊娠剧吐，体重减轻了13千克。由于症状难以忍受，患者要求终止妊娠，遂开始静脉注射米氮平（瑞美隆）治疗。
结果
恶心和呕吐在数小时内消失，患者不再要求终止妊娠。两周后患者健康出院，妊娠36周时进行了剖宫产。产后评估以及产后6个月的检查显示，孩子没有形态异常或实验室检查异常。
Zotero 插件